Abstract
In the last decade there has been a very active study of large microbial community in the human gut. The concept appeared explaining the development and persistence of symptoms in irritable bowel syndrome due to disturbances of the intestinal microbial landscape. Manipulation of the intestinal microflora represents a new strategy for treatment of this polietiologic disease. The modulation of the intestinal bacterial at which beneficial (Lactobacilli and Bifidobacteria) bacteria are increased and pathogenic bacteria (Clostridium, Escherichia coli, Salmonella, Shigella and Pseudomonas) are reduced should reduce the symptoms of the irritable bowel syndrome. In this conceptual framework, probiotics are the optimal option in terms of efficacy and safety, and they attract the attention of specialists prebiotics, synbiotics, antibiotics and fecal transplantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
